Stefano Fanti, MD of University of Bologna, Bologna, Italy discusses the use of PET/CT in prostate cancer at the European Cancer Congress of the European Cancer Organisation (ECCO) 2017 in Amsterdam, Netherlands. PET/CT is not typically used in early cancer detection, but rather in patients for example with castration resistant prostate cancer that have already been treated, in determining the most effective treatment.